发明名称 NEW PHARMACEUTICAL COMPOSITION
摘要 <p><P>PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for topical administration for prophylaxis and/or treatment of herpesvirus infections in mammals including human, and to provide a pharmaceutical composition for topical administration. <P>SOLUTION: The invention relates to pharmaceutical composition for transcutaneous administration or administration to mucosa, for prophylaxis and/or treatment of herpesvirus infections in mammals including human, comprising a combination of an antiviral substance such as foscarnet with the anti-inflammatory glucocorticoid such as a hydrocortisone in a pharmaceutically acceptable carrier. The composition is especially useful for treatment of recurrent herpesvirus infections. <P>COPYRIGHT: (C)2008,JPO&INPIT</p>
申请公布号 JP2007284452(A) 申请公布日期 2007.11.01
申请号 JP20070201681 申请日期 2007.08.02
申请人 MEDIVIR AB 发明人 HARMENBERG JOHAN GEORG;KRISTOFFERSON ANN HARRIET MARGARETA
分类号 A61K9/10;A61K31/662;A61K9/00;A61K9/107;A61K31/52;A61K31/56;A61K31/57;A61K31/573;A61K31/58;A61K31/66;A61K31/675;A61K31/70;A61K45/06;A61K47/00;A61K47/02;A61K47/06;A61K47/10;A61K47/12;A61P31/12;A61P31/22;A61P43/00 主分类号 A61K9/10
代理机构 代理人
主权项
地址